UCI Spearheads $109M Down Syndrome, Alzheimer’s Study

Alzheimer’s Biomarker Consortium – Down Syndrome (ABC-DS) Award

The University of California, Irvine is undertaking a five-year, multi-million dollar project to expand research on Alzheimer’s disease in people with Down syndrome. The National Institute of Health awarded a $109 million grant to the Alzheimer’s Biomarkers Consortium-Down Syndrome in late October. The international team, led by UCI principal investigators Elizabeth Head and Mark Mapstone, aims to identify biomarkers that indicate the progression of Alzheimer’s disease in adults with Down syndrome.

Subscribers to the Orange County Business Journal can read more here >